News Conference News AHA 2016 Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’ Michael O'Riordan November 21, 2016
News Conference News AHA 2016 Subclinical A-fib Common in Older, Asymptomatic Patients Todd Neale November 18, 2016
News Conference News AHA 2016 La FA Subclínica es Común en Pacientes Asintomáticos de Mayor Edad Todd Neale November 18, 2016
News Daily News Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians Caitlin E. Cox November 17, 2016
News Daily News Las Dudas en torno al Equilibrio Riesgos-Beneficios para los Filtros VCI Siguen Irritando a los Médicos Caitlin E. Cox November 17, 2016
News Conference News AHA 2016 Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women L.A. McKeown November 17, 2016
News Conference News AHA 2016 Proton Pump Inhibitor Use Tied to Elevated Ischemic Stroke Risk Todd Neale November 16, 2016
News Conference News AHA 2016 Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF Shelley Wood November 16, 2016
Presentation AHA 2016 Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF) Presenter: Dirk J. van Veldhuisen November 16, 2016
News Conference News AHA 2016 Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients Michael O'Riordan November 16, 2016
News Conference News AHA 2016 Según Datos a Nivel Nacional, las PCI realizadas en Centros Sin Soporte Quirúrgico ‘Probablemente No Tengan Problemas’ Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests Yael L. Maxwell November 16, 2016
News Conference News AHA 2016 Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results Todd Neale November 15, 2016
Presentation AHA 2016 Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial Presenter: David M Kaye November 15, 2016
Presentation AHA 2016 PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy Presenter: Michael Gibson November 15, 2016
Presentation AHA 2016 Arterial Revascularization Trial (ART) Presenter: David P. Taggart November 15, 2016